
Dr. Molly Imgruet is a Hematology/Oncology Fellow specializing in the treatment of blood cancers and malignancies. She is currently a Hematology/Oncology fellow at Stanford University, where she is engaged in cutting-edge translational research focused on cancer biology. Her academic journey began with a degree in Bioengineering from the University of Illinois Urbana-Champaign, where she developed a passion for biomedical research. She then earned her MD and PhD in Cancer Biology from the University of Chicago, with her doctoral work centered on epigenetics and DNA damage repair in therapy-related myeloid neoplasms. Her research interests include myeloid malignancies, clonal hematopoiesis, and the effects of aging on the bone marrow microenvironment. She has been recognized for her contributions with awards such as the 2019 American Society of Hematology Abstract Achievement Award and the Leon O. Jacobson Basic Science Prize from the University of Chicago. Dr. Imgruet’s fellowship at Stanford provides her with specialized training in innovative cancer therapies and translational research, positioning her at the forefront of personalized medicine in hematology and oncology.
Stanford Medicine
Medical School
Residency
2023 – 2025
Fellowship
2024 – present